Uncategorized

Arvinas’ ‘Protac’ breast cancer drug cleared by FDA

Published

on

Known as Veppanu, the drug is the first of its kind to get to market. But Arvinas and partner Pfizer are still searching for a new partner to sell it.

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version